Short answer: Quantum optimisation could one day help pharmaceutical plants schedule batches, lines and changeovers, but it is at the research and pilot stage. A case study published by Quantum Basel describes a hybrid quantum scheduling project at a Pfizer site in Freiburg, Germany. It is a vendor-published result with no figures, and no Irish plant is shown to use quantum optimisation in production.
Ireland is one of the world's significant locations for pharmaceutical manufacturing. Plants here run expensive equipment, strict quality rules and tight delivery promises. The daily question inside each plant is deceptively simple: which batch runs on which line, in what order, and when? This is a scheduling problem, and scheduling is one of the areas where researchers are testing quantum optimisation.
Why scheduling is hard
Production scheduling belongs to a family of combinatorial optimisation problems. Add one more product, one more machine or one more constraint, and the number of possible schedules grows very quickly. Real plants add further rules: cleaning between products, equipment that can only run some recipes, staff shifts, material availability and regulatory hold times. Classical software handles this well with good heuristics, but for large, tightly constrained cases the answers can be far from the best possible.
Better schedules matter in concrete ways. They can mean less idle equipment, shorter changeover time, fewer late orders and a plant that copes better when something changes at short notice.
What a hybrid quantum approach means
Today's quantum hardware is small and noisy. So the approaches being tried are hybrid. A classical computer handles most of the work and sends a carefully shaped part of the optimisation problem to a quantum processor or a quantum-inspired solver. The result is fed back into the classical workflow. The aim is not to replace existing scheduling software. The aim is to test whether the quantum step improves the answers on hard cases.
A worked example from outside Ireland
One published example comes from Pfizer, which operates a global network across research, manufacturing and distribution, with products in areas such as oncology, immunology and vaccines. A case study published by Quantum Basel describes a project at Pfizer's Freiburg manufacturing site to improve scheduling efficiency using hybrid quantum optimisation.
In the case study, Pembe Gül Bilir, a Project Engineer in Innovation at Pfizer Freiburg, says the results seen at the site show that hybrid quantum approaches enhance scheduling performance and support a more agile manufacturing process.
Two cautions belong with that. First, this is a statement from a case study published on the website of Quantum Basel, a quantum technology provider, so it should be read as a vendor-published result and not an independent benchmark. The source we reviewed does not give us the figures needed to judge the size of the improvement. Second, one site's experience does not show that the approach works across plants or scales to every problem. It does show that a large pharmaceutical manufacturer considered the approach worth testing on a real production problem.
What this could mean for Irish pharma
The case shows a pattern that Irish manufacturers could follow. It is a proposal for a low-risk way to start, not a claim that anyone here has done it:
- Pick one painful scheduling problem. Choose a line or area where schedules are tight and changeovers are costly.
- Keep the current scheduler. Run the quantum or hybrid method alongside it on the same data, offline.
- Compare on agreed measures. Use makespan, late orders, changeover time and how well a schedule survives a disruption.
- Respect validation rules. Pharmaceutical plants work under strict quality systems, so anything that touches production planning needs change control. An offline trial avoids touching validated systems.
Where this stands
This use case is at the research and pilot stage. The published example is one case study from a technology provider. There is no basis here to say that Irish plants run quantum optimisation in production today, and this article does not claim it. What it shows is a direction and a practical way to test it.
For the wider picture, a realistic expectation is that hybrid methods may help on some hard scheduling cases well before fault-tolerant quantum computers exist, while improvements in classical algorithms will keep raising the bar that quantum methods have to beat.
The takeaway
Scheduling is a good early test for quantum optimisation because the problem is clear, the data exists and success is easy to measure. For Irish pharmaceutical manufacturing, the sensible step is a small offline comparison on one real scheduling problem, judged on plain operational numbers.
FAQ
Is quantum computing used to schedule pharmaceutical manufacturing today?
Not in any way shown by the sources reviewed. A Quantum Basel case study describes a hybrid quantum scheduling project at a Pfizer site in Freiburg, but it is a vendor-published account and does not give the figures needed to judge the improvement.
What is a hybrid quantum approach to scheduling?
A classical computer does most of the work and sends a shaped part of the optimisation problem to a quantum processor or a quantum-inspired solver. The result goes back into the classical workflow. The aim is to test whether the quantum step improves answers on hard cases, not to replace existing scheduling software.
Why is production scheduling hard for classical software?
It is a combinatorial optimisation problem. Each extra product, machine or constraint, such as cleaning between products or staff shifts, makes the number of possible schedules grow very quickly. Good heuristics work well, but large, tightly constrained cases can end up far from the best possible schedule.
How could an Irish manufacturer test this safely?
By running a quantum or hybrid method offline, alongside the current scheduler, on one real scheduling problem and comparing makespan, late orders, changeover time and resilience to disruption. An offline trial avoids touching validated production systems.
Does this mean quantum computers will beat classical scheduling software?
No. Hybrid methods may help on some hard cases before fault-tolerant quantum computers exist, but improvements in classical algorithms keep raising the bar quantum methods have to beat.
All field notes